Carvedilol Reestablishes Long-Term Potentiation in a Mouse Model of alzheimer's Disease

被引:30
|
作者
Arrieta-Cruz, Isabel [1 ]
Wang, Jun [1 ]
Pavlides, Constantine [2 ]
Pasinetti, Giulio Maria [1 ,3 ]
机构
[1] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA
[2] Rockefeller Univ, New York, NY 10021 USA
[3] James J Peters Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Bronx, NY USA
关键词
Alzheimer's disease; carvedilol; epileptic discharges; hippocampus; LTP; neuronal transmission; synaptic plasticity; TgCRND8; mice; ADRENERGIC-RECEPTOR ACTIVATION; MICE; STIMULATION; EPILEPSY; LTP;
D O I
10.3233/JAD-2010-100225
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In this study, we examined acute effects of carvedilol, a nonselective alpha/beta-adrenergic receptor blocker, on neuronal transmission and long-term potentiation (LTP) in six month-old TgCRND8 mice and their wild-type age-matched controls. Field excitatory postsynaptic potentials were recorded in the CA1 region of the hippocampus from carvedilol-or vehicle dimethyl sulfoxide-treated slices, and differences in basal synaptic transmission and LTP were assessed. Carvedilol treatment produced a significant increase in basal synaptic transmission and LTP in TgCRND8 mice, as compared to their vehicle-treated slices, in which basal neuronal transmission and LTP decreased. Interestingly, carvedilol significantly suppressed spontaneous seizure activity in TgCRND8 mice as measured by the number of slices showing epileptic discharges as well as the number of spikes within these and the amplitude of the second spike, measured at baseline and end of recording. In contrast, vehicle-treated slices in TgCRND8 mice did not show a significant decrease in epileptic discharges. These results suggest that carvedilol reestablishes basal synaptic transmission, enhances neuronal plasticity and suppresses neuronal hyperexcitability in TgCRND8 mice.
引用
收藏
页码:649 / 654
页数:6
相关论文
共 50 条
  • [41] Alzheimer's disease - A long-term study with Donepezil
    Diener, HC
    PSYCHOPHARMAKOTHERAPIE, 1999, 6 (02): : 75 - 76
  • [42] Long-term treatment of Alzheimer's disease with idebenone
    Gutzmann, H
    Hadler, D
    Erzigkeit, H
    ALZHEIMER'S DISEASE: BIOLOGY, DIAGNOSIS AND THERAPEUTICS, 1997, : 687 - 705
  • [43] Long-term forgetting in preclinical Alzheimer's disease
    Reiman, Eric M.
    LANCET NEUROLOGY, 2018, 17 (02): : 104 - 105
  • [44] Long-term effects of Alzheimer's disease treatment
    Wimo, Anders
    LANCET NEUROLOGY, 2015, 14 (12): : 1145 - 1146
  • [45] Metrifonate in the long-term treatment of Alzheimer's disease
    Cyrus, PA
    Ruzicka, B
    Gulanski, B
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1998, 46 (09) : S35 - S35
  • [46] Long-term effects of Alzheimer's disease treatment
    Atri, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 661 - 661
  • [47] Tonic inhibition in dentate gyrus impairs long-term potentiation and memory in an Alzheimer's disease model (vol 5, 4159, 2014)
    Wu, Zheng
    Guo, Ziyuan
    Gearing, Marla
    Chen, Gong
    NATURE COMMUNICATIONS, 2014, 5
  • [48] Long-Term Dietary Supplementation of Pomegranates, Figs and Dates Alleviate Neuroinflammation in a Transgenic Mouse Model of Alzheimer's Disease
    Essa, Musthafa Mohamed
    Subash, Selvaraju
    Akbar, Mohammed
    Al-Adawi, Samir
    Guillemin, Gilles J.
    PLOS ONE, 2015, 10 (03):
  • [49] Long-term treatment with galantamine in patients with Alzheimer's disease and Alzheimer's disease with cerebrovascular disease
    Feldman, H
    Van Baelen, B
    Brashear, HR
    Schwalen, S
    Kavanagh, S
    NEUROBIOLOGY OF AGING, 2004, 25 : S198 - S199
  • [50] Dexmedetomidine reduces long-term potentiation in mouse hippocampus
    Takamatsu, Isao
    Iwase, Ayano
    Ozaki, Makoto
    Kazama, Tomiei
    Wada, Keiji
    Sekiguchi, Masayuki
    ANESTHESIOLOGY, 2008, 108 (01) : 94 - 102